UCL: Second generation CAR T-cell therapy trialled in patients

Researchers say the findings offer new hope to adult patients with ‘relapsed B-cell acute lymphoblastic leukaemia’ (r/r B-ALL), for which there is currently no approved ‘curative’ treatment available. Patients typically have further chemotherapy and

Related Keywords

United States ,United Kingdom ,Karl Peggs ,Claire Evans ,Claire Roddie ,National Institute For Health Research ,Sir Naim Dangoor Centre For Cellular Immunotherapy ,Claire ,Biomedical Research Centre ,Cancer Institute ,Clinical Oncology ,National Institute ,Health Research ,Research Centre ,Investigator Professor Karl Peggs ,Honorary Clinical Professor ,Sir Naim Dangoor Centre ,Associate Professor ,Autolus Therapeutics ,Acute Lymphoblastic Leukaemia ,